These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway. Ren S; Wang Y; Zhang Y; Yan P; Xiao D; Zhao Y; Jia W; Ding L; Dong H; Wei C; Lin S; Lin Y Biomed Pharmacother; 2023 Sep; 165():115253. PubMed ID: 37542855 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy. Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837 [TBL] [Abstract][Full Text] [Related]
4. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice. Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress. Li R; Qi Y; Yuan Q; Xu L; Gao M; Xu Y; Han X; Yin L; Liu C Eur J Pharmacol; 2021 Sep; 907():174277. PubMed ID: 34171391 [TBL] [Abstract][Full Text] [Related]
6. [Fucoxanthin regulates Nrf2/Keap1 signaling to alleviate myocardial hypertrophy in diabetic rats]. Zheng D; Chen L; Wei Q; Zhu Z; Liu Z; Jin L; Yang G; Xie X Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):752-759. PubMed ID: 35673921 [TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway. Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453 [TBL] [Abstract][Full Text] [Related]
8. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway. Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738 [TBL] [Abstract][Full Text] [Related]
9. GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress. Liu J; Li X; Ding L; Li W; Niu X; Gao D Int Immunopharmacol; 2023 Apr; 117():109957. PubMed ID: 37012864 [TBL] [Abstract][Full Text] [Related]
10. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115 [TBL] [Abstract][Full Text] [Related]
11. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice. Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521 [TBL] [Abstract][Full Text] [Related]
12. Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway. Zhang L; Zhang W; Zheng B; Tian N Neurochem Res; 2019 Apr; 44(4):763-775. PubMed ID: 30603983 [TBL] [Abstract][Full Text] [Related]
13. Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488 [TBL] [Abstract][Full Text] [Related]
14. CD38 promotes angiotensin II-induced cardiac hypertrophy. Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029 [TBL] [Abstract][Full Text] [Related]
15. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway. Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333 [TBL] [Abstract][Full Text] [Related]
16. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ]. Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329 [TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity. Yan L; Zhang JD; Wang B; Lv YJ; Jiang H; Liu GL; Qiao Y; Ren M; Guo XF PLoS One; 2013; 8(9):e72548. PubMed ID: 24039778 [TBL] [Abstract][Full Text] [Related]
18. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis. Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004 [TBL] [Abstract][Full Text] [Related]
19. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway. Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571 [TBL] [Abstract][Full Text] [Related]
20. Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis. Velusamy P; Mohan T; Ravi DB; Kishore Kumar SN; Srinivasan A; Chakrapani LN; Singh A; Varadharaj S; Kalaiselvi P Oxid Med Cell Longev; 2020; 2020():9568278. PubMed ID: 32952852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]